Heron Therapeutics, Inc. (HRTX)

NASDAQ

$0.37

$--

(0.00%)

Pre-Market

Heron Therapeutics, Inc. (HRTX) Live Price Chart

Last updated: ⁦2026-11-11 12:25:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Heron Therapeutics, Inc. (HRTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.37, with a market capitalization of $70.36M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.26 to $1.58. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$70.36M
Open	$0.37
Day's High	$42.90
Day's Low	$0.26
Previous Close	$0.37
Volume	58.51K
Average Volume	4.48M
P/E Ratio	--
52-Week High	$1.58
52-Week Low	$0.26
Dividend Yield	--
Earnings Date	--

Heron Therapeutics, Inc. (HRTX) Pre-Market Stock Price

Heron Therapeutics, Inc. (HRTX) is trading at $0.37 in pre-market trading as of 2026-11-11 12:15:00, down 0.29% ($0.00) from the previous close of $0.37

Pre-market trading shows how investors are pricing HRTX before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Heron Therapeutics, Inc. (HRTX) 7-Day Stock Price Change

Over the past seven days, Heron Therapeutics, Inc. (HRTX) moved from $0.30 to $0.37, representing a gain of 26.40% ($0.08).

The stock traded between $0.27 and $0.42 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 22.33 million shares, up versus the previous seven-day period, indicating higher trading activity.

HRTX 52-Week Price Position

Position in Range: 8.5%

52W Low$0.26

52W High$1.58

HRTX is currently trading at $0.37, placing it 8.5% of the way from its 52-week low of $0.26 to its 52-week high of $1.58. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Heron Therapeutics, Inc. (HRTX)?

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Heron Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	128
Exchange	NASDAQ
Company Website	https://www.herontx.com

How to Buy Heron Therapeutics, Inc. (HRTX) Stock on MEXC

Eligible investors can buy real shares of Heron Therapeutics, Inc. (HRTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for HRTX and Place Your Order

Open the RealStocks trading page and search for HRTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Heron Therapeutics, Inc. (HRTX) stock price today?

Heron Therapeutics, Inc. (HRTX) is currently trading at $ 0.37, down 0.29% ($0.00) from the previous close of $ 0.37. Intraday prices update in real time during regular trading hours.

2.Is HRTX stock going up or down today?

As of 2026-11-11 12:15:00, HRTX is trading at $ 0.37, down 0.29% ($0.00) from its previous close of $ 0.37. The stock has traded between $ 0.26 and $ 42.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is HRTX pre-market price?

As of 2026-11-11 12:15:00, HRTX is trading at $ 0.37 in pre-market trading, down 0.29% ($0.00) from the previous close of $ 0.37. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is HRTX after-hours price?

As of 2026-11-11 12:15:00, HRTX is trading at $ 0.37 in after-hours trading, down 0.29% ($0.00) from the regular-session close of $ 0.37. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is HRTX stock trading now?

HRTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does HRTX sit relative to its 52-week high and low?

Over the past 52 weeks, HRTX has traded between a low of $ 0.26 and a high of $ 1.58. At $ 0.37, the stock is positioned 8.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Heron Therapeutics, Inc. in?

Heron Therapeutics, Inc. (HRTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Heron Therapeutics, Inc.'s market capitalization and where is it listed?

Heron Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 70.36M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is HRTX valued in terms of P/E ratio and EPS?

HRTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Heron Therapeutics, Inc. pay a dividend?

Heron Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.